How COVID-19 Affected the Introduction of Telemedicine and Patient Reported Outcomes Among Patients With Pulmonary Hypertension　― A Report From a Referral Center in Japan ―

Yuichi Tamura; Rika Takeyasu; Asuka Furukawa; Hiromi Takada; Mineki Takechi; Hirohisa Taniguchi; Akio Kawamura

doi:10.1253/circrep.CR-20-0088

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

How COVID-19 Affected the Introduction of Telemedicine and Patient Reported Outcomes Among Patients With Pulmonary Hypertension　― A Report From a Referral Center in Japan ―

Yuichi Tamura, Rika Takeyasu, Asuka Furukawa, Hiromi Takada, Mineki Takechi, Hirohisa Taniguchi, Akio Kawamura

著者情報

キーワード: COVID-19, emPHasis-10, Patient-reported outcome, Pulmonary hypertension, Telemedicine

ジャーナルオープンアクセス HTML 早期公開
電子付録

論文ID: CR-20-0088

DOI https://doi.org/10.1253/circrep.CR-20-0088

この記事には本公開記事があります。

The final version of this article is now available: Vol. 2 (2020), No. 9 pp. 526-530

詳細

抄録

Background:COVID-19 is fatal to patients with pulmonary hypertension (PH), so preventive actions are recommended. This study investigated the effectiveness of telemedicine and effects on quality of life (QOL) in the treatment of patients with PH.

Methods and Results:Japanese patients with PH (n=40) were recruited from one referral center. Patient self-reported anxiety worsened significantly and elderly patients in particular experienced detrimental lifestyle changes under COVID-19. Telemedicine worked well to decrease the frequency of going out.

Conclusions:Telemedicine is effective in reducing travel distances, and frequent remote interventions may be desirable for older, anxious patients.

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）